Phenprobamate

Revision as of 16:55, 20 August 2015 by WikiBot (talk | contribs) (Protected "Phenprobamate": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Phenprobamate
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Pharmacokinetic data
Elimination half-life5 - 8 hours
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC10H13NO2
Molar mass179.22
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Phenprobamate

Articles

Most recent articles on Phenprobamate

Most cited articles on Phenprobamate

Review articles on Phenprobamate

Articles on Phenprobamate in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Phenprobamate

Images of Phenprobamate

Photos of Phenprobamate

Podcasts & MP3s on Phenprobamate

Videos on Phenprobamate

Evidence Based Medicine

Cochrane Collaboration on Phenprobamate

Bandolier on Phenprobamate

TRIP on Phenprobamate

Clinical Trials

Ongoing Trials on Phenprobamate at Clinical Trials.gov

Trial results on Phenprobamate

Clinical Trials on Phenprobamate at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Phenprobamate

NICE Guidance on Phenprobamate

NHS PRODIGY Guidance

FDA on Phenprobamate

CDC on Phenprobamate

Books

Books on Phenprobamate

News

Phenprobamate in the news

Be alerted to news on Phenprobamate

News trends on Phenprobamate

Commentary

Blogs on Phenprobamate

Definitions

Definitions of Phenprobamate

Patient Resources / Community

Patient resources on Phenprobamate

Discussion groups on Phenprobamate

Patient Handouts on Phenprobamate

Directions to Hospitals Treating Phenprobamate

Risk calculators and risk factors for Phenprobamate

Healthcare Provider Resources

Symptoms of Phenprobamate

Causes & Risk Factors for Phenprobamate

Diagnostic studies for Phenprobamate

Treatment of Phenprobamate

Continuing Medical Education (CME)

CME Programs on Phenprobamate

International

Phenprobamate en Espanol

Phenprobamate en Francais

Business

Phenprobamate in the Marketplace

Patents on Phenprobamate

Experimental / Informatics

List of terms related to Phenprobamate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Phenprobamate (Gamaquil, Isotonil) is a centrally acting skeletal muscle relaxant, with additional sedative and anticonvulsant effects. Overdose is similar to barbiturate. Its mechanism of action is probably similar to meprobamate. Phenprobamate was previously used in humans as an anxiolytic, and is still sometimes used in general anaesthesia and for treating muscle cramps and spasticity. Phenprobamate is still used in some european countries, but it has generally been replaced by newer drugs. Phenprobamate is metabolised by oxidative degradation of the amide group and ortho-hydroxylation of the benzene ring, and is eliminated in urine by the kidneys.


Dose: 400 - 800 mg, up to 3 times a day.


References